CME Group Inc. (NASDAQ:CME) Shares Acquired by Trust Co. of Toledo NA OH

Trust Co. of Toledo NA OH lifted its stake in shares of CME Group Inc. (NASDAQ:CME) by 1.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 8,914 shares of the financial services provider’s stock after purchasing an additional 107 shares during the period. Trust Co. of Toledo NA OH’s holdings in CME Group were worth $2,070,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of CME. Coronation Fund Managers Ltd. bought a new stake in shares of CME Group during the 2nd quarter worth about $313,000. Private Advisor Group LLC raised its position in shares of CME Group by 13.1% in the second quarter. Private Advisor Group LLC now owns 5,193 shares of the financial services provider’s stock valued at $1,021,000 after purchasing an additional 601 shares during the period. LPL Financial LLC lifted its stake in shares of CME Group by 3.5% in the second quarter. LPL Financial LLC now owns 181,373 shares of the financial services provider’s stock worth $35,658,000 after buying an additional 6,178 shares during the last quarter. American Century Companies Inc. boosted its holdings in shares of CME Group by 2.8% during the 2nd quarter. American Century Companies Inc. now owns 47,606 shares of the financial services provider’s stock worth $9,359,000 after buying an additional 1,294 shares during the period. Finally, Main Street Financial Solutions LLC grew its stake in CME Group by 5.9% in the 2nd quarter. Main Street Financial Solutions LLC now owns 1,212 shares of the financial services provider’s stock valued at $238,000 after buying an additional 68 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME stock traded up $0.66 on Monday, hitting $229.86. The company’s stock had a trading volume of 281,553 shares, compared to its average volume of 1,890,082. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $249.02. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s 50 day moving average is $232.56 and its 200-day moving average is $218.87. The company has a market capitalization of $82.83 billion, a PE ratio of 24.17, a PEG ratio of 5.41 and a beta of 0.56.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The business had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.25 earnings per share. Equities research analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group announced that its Board of Directors has approved a stock repurchase program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its stock is undervalued.

CME Group Increases Dividend

The firm also recently announced a dividend, which will be paid on Thursday, January 16th. Shareholders of record on Friday, December 27th will be given a $5.80 dividend. The ex-dividend date of this dividend is Friday, December 27th. This is a boost from CME Group’s previous dividend of $2.50. CME Group’s payout ratio is currently 48.37%.

Insiders Place Their Bets

In other CME Group news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the sale, the director now directly owns 25,067 shares of the company’s stock, valued at $5,587,935.64. The trade was a 1.57 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Sunil Cutinho sold 4,500 shares of the business’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total transaction of $1,019,880.00. Following the completion of the sale, the insider now directly owns 27,053 shares in the company, valued at approximately $6,131,291.92. This represents a 14.26 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,274 shares of company stock valued at $1,648,071. 0.30% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of analyst reports. Royal Bank of Canada restated a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft cut their target price on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Morgan Stanley upped their price target on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research report on Thursday, October 17th. TD Cowen initiated coverage on shares of CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 target price on the stock. Finally, Piper Sandler increased their target price on shares of CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, CME Group has a consensus rating of “Hold” and a consensus price target of $229.53.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.